Prakash Nidadavolu
Overview
Explore the profile of Prakash Nidadavolu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Effah F, Nidadavolu P, de Gusmao Taveiros Silva N, Wojtowicz M, Camarini R, Zimmer A, et al.
Eur J Neurosci
. 2024 Oct;
60(11):6686-6703.
PMID: 39435722
Aging is often associated with changes in social, sexual, emotional and pain functioning, as well as with the increased prevalence of certain psychopathologies. However, the neurodevelopmental basis underpinning these age-related...
2.
Bilkei-Gorzo A, Schurmann B, Schneider M, Kraemer M, Nidadavolu P, Beins E, et al.
ACS Pharmacol Transl Sci
. 2024 Sep;
7(9):2637-2649.
PMID: 39296258
Brain aging is associated with cognitive decline, reduced synaptic plasticity, and altered metabolism. The activity of mechanistic target of rapamycin (mTOR) has a major impact on aging by regulating cellular...
3.
Nidadavolu P, Bilkei-Gorzo A, Effah F, Leidmaa E, Schurmann B, Berger M, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142165
Endocannabinoid (eCB) signaling is markedly decreased in the hippocampus (Hip) of aged mice, and the genetic deletion of the cannabinoid receptor type 1 (CB1) leads to an early onset of...
4.
Nidadavolu P, Bilkei-Gorzo A, Kramer M, Schurmann B, Palmisano M, Beins E, et al.
Front Aging Neurosci
. 2021 Sep;
13:718850.
PMID: 34526890
Decline in cognitive performance, an aspect of the normal aging process, is influenced by the endocannabinoid system (ECS). Cannabinoid receptor 1 (CB1) signaling diminishes with advancing age in specific brain...
5.
Kraemer M, Hess C, Maas A, Madea B, Bilkei-Gorzo A, Nidadavolu P
Drug Metab Pers Ther
. 2021 Aug;
36(3):199-203.
PMID: 34412174
Objectives: In a previous investigation we searched for the occurrence of palmitic acid ester compounds of delta9-tetrahydrocannabinol (THC) and its primary metabolite 11-hydroxy-delta9-THC (11-OH-THC) in human body fluids and tissues...
6.
Kraemer M, Hess C, Maas A, Madea B, Bilkei-Gorzo A, Nidadavolu P
Drug Metab Pers Ther
. 2021 Mar;
PMID: 33742956
Objectives: In a previous investigation we searched for the occurrence of palmitic acid ester compounds of delta9-tetrahydrocannabinol (THC) and its primary metabolite 11-hydroxy-delta9-THC (11-OH-THC) in human body fluids and tissues...
7.
Meka D, Muller-Rischart A, Nidadavolu P, Mohammadi B, Motori E, Ponna S, et al.
J Clin Invest
. 2015 Mar;
125(5):1873-85.
PMID: 25822020
Parkin and the glial cell line-derived neurotrophic factor (GDNF) receptor RET have both been independently linked to the dopaminergic neuron degeneration that underlies Parkinson's disease (PD). In the present study,...
8.
Ahmad F, Nidadavolu P, Durgadoss L, Ravindranath V
Free Radic Biol Med
. 2014 Jun;
74:118-28.
PMID: 24933620
Impaired Akt1 signaling is observed in neurodegenerative diseases, including Parkinson׳s disease (PD). In PD models oxidative modification of Akt1 leads to its dephosphorylation and consequent loss of its kinase activity....
9.
Durgadoss L, Nidadavolu P, Valli R, Saeed U, Mishra M, Seth P, et al.
FASEB J
. 2011 Dec;
26(4):1473-83.
PMID: 22198382
Impairment of Akt phosphorylation, a critical survival signal, has been implicated in the degeneration of dopaminergic neurons in Parkinson's disease. However, the mechanism underlying pAkt loss is unclear. In the...
10.
Saeed U, Karunakaran S, Meka D, Koumar R, Ramakrishnan S, Joshi S, et al.
Neurotox Res
. 2009 Jun;
16(2):116-26.
PMID: 19526288
Incidence of Parkinson's disease (PD) is lower in women compared to men (1:1.46), which is reflected in animal models. However, precise mechanisms are unclear. Administration of MPTP (1-methyl-4-phenyl-1, 2, 3,...